Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline PART II.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 20 2 2021
Statut: ppublish

Résumé

The summary presented herein represents Part II of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part II outlines the appropriate management of the male in an infertile couple. Medical therapies, surgical techniques, as well as use of intrauterine insemination (IUI)/in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) are covered to allow for optimal patient management. Please refer to Part I for discussion on evaluation of the infertile male and discussion of relevant health conditions that are associated with male infertility. The Emergency Care Research Institute Evidence-based Practice Center team searched PubMed®, Embase®, and Medline from January 2000 through May 2019. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions (table[Table: see text]). This summary is being simultaneously published in Fertility and Sterility and The Journal of Urology. This Guideline provides updated, evidence-based recommendations regarding management of male infertility. Such recommendations are summarized in the associated algorithm (figure[Figure: see text]). Male contributions to infertility are prevalent, and specific treatment as well as assisted reproductive techniques are effective at managing male infertility. This document will undergo additional literature reviews and updating as the knowledge regarding current treatments and future treatment options continues to expand.

Identifiants

pubmed: 33295258
doi: 10.1097/JU.0000000000001520
doi:

Substances chimiques

Selective Estrogen Receptor Modulators 0

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-51

Auteurs

Peter N Schlegel (PN)

New York Presbyterian Hospital-Weill Cornell Medical College.

Mark Sigman (M)

Brown University.

Christopher J De Jonge (CJ)

University of Minnesota School of Medicine.

Michael L Eisenberg (ML)

Stanford University School of Medicine.

Dolores J Lamb (DJ)

Weill Cornell Medical College.

John P Mulhall (JP)

Memorial-Sloan Kettering Cancer Center, Weill Cornell Medicine.

Craig Niederberger (C)

University of Illinois-Chicago School of Medicine.

Jay I Sandlow (JI)

Medical College of Wisconsin.

Rebecca Z Sokol (RZ)

University of Southern California School of Medicine.

Steven D Spandorfer (SD)

Weill Cornell Medical College.

Cigdem Tanrikut (C)

Georgetown University School of Medicine.

Armand Zini (A)

McGill University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH